The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The TacroType test provides actionable genetic insights to help clinicians understand how individual patients metabolize tacrolimus
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
If approved, imlifidase has the potential to transform the kidney transplant landscape by enabling highly sensitized patients to also have access to a potentially life-changing kidney transplant
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
The complex four-hour surgery was performed by a multidisciplinary team of doctors
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Subscribe To Our Newsletter & Stay Updated
